High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
High-dose Dexamethasone and Conventional Dose Prednisone, for the First-line Treatment of Adults With ITP: a Multicenter, Randomized Controlled, Clinical Trial
Sponsor: Anhui Provincial Hospital
A PHASE4 clinical study on Purpura, Thrombocytopenic, Idiopathic, this trial is completed. The trial is conducted by Anhui Provincial Hospital and has accumulated 12 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Aug 2025 — Sep 2025 [monthly]
Completed PHASE4
-
Sep 2024 — Aug 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Completed PHASE4
▶ Show 7 earlier versions
-
Dec 2022 — Oct 2023 [monthly]
Completed PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE4
-
Dec 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Aug 2018 — Dec 2018 [monthly]
Completed PHASE4
-
Jul 2018 — Aug 2018 [monthly]
Completed PHASE4
-
Jun 2018 — Jul 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Sep 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Anhui Provincial Hospital
- Chinese Academy of Medical Sciences
- Peking Union Medical College Hospital
- People's Hospital of Xinjiang Uygur Autonomous Region
- Ruijin Hospital
- Second Hospital of Shanxi Medical University
- Shandong University
- Shandong University of Traditional Chinese Medicine
- Shenzhen Second People's Hospital
- Tongji Hospital
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Zhejiang Provincial Hospital of TCM
For direct contact, visit the study record on ClinicalTrials.gov .